Nebius Stock Is Down Over 20% From Its High. Is Now the Time to Buy?

Nebius posted 454% quarterly revenue growth to $582 million, but also recorded a $190 million net loss and trades at roughly 45x forward earnings versus about 20x for the S&P 500. Shares remain up more than 170% year-to-date despite falling over 20% from their nearly $300 52-week high. The article argues that elevated valuation, recent Fed rate increases, and potential moderation in AI spending create meaningful downside risk, recommending investors wait before buying.

Analysis

NBIS is best viewed as a duration-sensitive AI-infrastructure asset rather than a conventional software compounder: its valuation requires sustained capacity utilization, rapid pricing realization, and a credible path from buildout losses to free-cash-flow generation. The key near-term issue is not demand headlines but whether incremental revenue is coming from contracted, creditworthy customers at utilization levels high enough to absorb GPU depreciation, power, and financing costs. A lower growth rate can produce a nonlinear equity drawdown because both forward estimates and the terminal multiple would reset simultaneously.

Over the next 1-3 months, the relevant catalysts are any disclosure on backlog quality, customer concentration, committed versus on-demand capacity, GPU procurement commitments, and cash burn. NBIS's equity is vulnerable if hyperscalers or model labs shift workloads in-house, renegotiate capacity, or defer deployments; that would also pressure smaller GPU-cloud peers before materially affecting NVDA, whose demand is diversified across buyers and geographies. Conversely, a verified multi-year take-or-pay contract or evidence that gross margin expands despite new capacity would challenge the short thesis.

The contrarian point is that the recent decline alone does not create a margin of safety: a stock can remain expensive while consensus has not yet modeled the full depreciation and financing burden of aggressive infrastructure expansion. However, an outright directional short carries squeeze risk given AI momentum, limited float/liquidity dynamics, and the possibility of strategic financing or customer announcements. Express the view through relative value and defined-risk options rather than unhedged exposure.

Key Decisions for Investors

• Initiate a 1-3 month pair: short NBIS / long NVDA, sized beta-neutral. The trade isolates GPU-cloud execution and capital-intensity risk from broad AI demand; cover the NBIS leg if it reports contracted backlog sufficient to support utilization above roughly 75% or raises full-year margin guidance.
• For defined downside exposure, buy NBIS 3-6 month put spreads after volatility normalizes rather than chase downside immediately; target a 15-25% further decline scenario from estimate cuts and multiple compression, while capping loss to premium paid.
• Do not add long NBIS until the next earnings release demonstrates sequential improvement in gross margin and cash burn alongside customer-contract detail. Revenue growth without utilization, capex, and contract-duration disclosure is not a sufficient underwriting signal.
• Monitor NVDA for a read-through, but avoid using NBIS weakness as a standalone NVDA short signal. A broad reduction in neocloud capacity orders would be more actionable only if accompanied by channel evidence of GPU delivery deferrals or downward revisions to hyperscaler capex.